HCA Healthcare (HCA) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
HCA Healthcare · Health Care · ref. ETF XLV · 95 calls · price $460.75
What the company does: HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
📈 HCA Healthcare (HCA) stock price
$460.75+10.1% over range
Oct 14, 25low $361.32 · high $545.13Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
67% recommend buying · 18 analysts
📊 JPI status : HCA Healthcare has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 HCA price target & analyst consensus — price $461
The price target · all analysts combined (18 targets)
Highest target · 1 firm of 18$579+25.7%
Median target · of 18 targets$480+4.2%
Lowest target · 1 firm of 18$380-17.5%
Current price$460.75
Where these 18 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1056%
$475 ↔ $579
Below
844%
$380 ↔ $460
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: BMO Capital — 73% of its targets hit on this sector (240 calls tested). It aims for $495 (+7.4 %), call made on September 24, 2026, maturing on September 24, 2027 (20 d ago).
The 13 reliable analysts
$475+3.1 %
The 5 other firms
$496+7.7 %
How to read it: the 13 reliable firms are not filtered by optimism — 7 aim above the price, 6 below, hence their $475 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 18 ratings (last 6 months)
Strong Buy00%
Buy1267%
Hold528%
Sell16%
Strong Sell00%
Go deeper on the analysts
🎯 HCA price target all
All 18 calls, one by one, with our verdict on each firm.
→ See all 18 targets, analyst by analyst💡 The best analysts on HCA most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in HCA? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about HCA Healthcare? The JPI assistant answers using our backtest data.
💰 HCA Healthcare dividend: yield, history & growth › open the full page
0.76%annual yield
📈 Steady dividend — 5 yrs of consecutive dividend increases
That's ~$3.00 per share per year.
📈 HCA Healthcare fundamentals: valuation, margins & growth › open the full page
P/E 15.4Net margin 8.8 %Revenue growth +8.7 %Fairly valued
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 9 %
2023
Rev +8%Profit −7%
2024
Rev +9%Profit +10%
2025
Rev +7%Profit +18%
🔎 Detailed analyses
🏛️ Which US Congress members hold HCA Healthcare (HCA)?
4 Congress members have disclosed HCA buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
✅ Historical analyst reliability on HCA
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| SunTrust Robinson Humphrey | 100% | +87.7% | 2 |
| Loop Capital ↗ | 100% | +37.8% | 2 |
| Imperial Capital | 100% | +36.8% | 2 |
| JP Morgan ↗ | 100% | +33.1% | 9 |
| Bernstein ↗ | 100% | +19.4% | 2 |
| TD Cowen ↗ | 100% | +17.4% | 3 |
| RBC Capital ↗ | 90% | +21.1% | 21 |
| Mizuho ↗ | 89% | +30.3% | 19 |
| Stephens & Co. ↗ | 89% | +22.7% | 9 |
| SVB Leerink | 88% | +22.2% | 8 |
See the other 20 firms
| Wells Fargo ↗ | 33% | -13.2% | 3 |
| Morgan Stanley ↗ | 50% | -10.9% | 6 |
| Barclays ↗ | 55% | +13.4% | 20 |
| Leerink Swann | 60% | +13.1% | 5 |
| BMO Capital ↗ | 60% | +21.2% | 5 |
| Goldman Sachs ↗ | 62% | +15.1% | 8 |
| UBS ↗ | 64% | +23.3% | 11 |
| Cowen & Co. | 67% | +4.2% | 3 |
| Citigroup ↗ | 67% | +20.7% | 12 |
| Oppenheimer ↗ | 73% | +9.6% | 11 |
| Jefferies ↗ | 75% | +28.0% | 8 |
| Keybanc ↗ | 80% | +17.1% | 5 |
| Argus Research ↗ | 80% | +22.5% | 5 |
| Baird ↗ | 80% | +29.8% | 5 |
| B of A Securities ↗ | 83% | +7.8% | 6 |
| Deutsche Bank ↗ | 83% | +21.7% | 18 |
| Raymond James ↗ | 85% | +32.0% | 20 |
| Cantor Fitzgerald ↗ | 86% | +17.5% | 21 |
| Credit Suisse | 86% | +26.8% | 21 |
| Truist Securities ↗ | 86% | +28.1% | 14 |
📊 What $1,000 invested in HCA Healthcare would be worth › open the full page
In short — $1,000 invested in HCA Healthcare 10 years ago would be worth $5,765 today, i.e. +19%/yr on average. Best year: 2021 (+56%), worst: 2022 (-7%). Price performance, excluding dividends.
If I'd invested $1,000 in HCA Healthcare
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,299 | +30% |
| 3 years ago | $1,625 | +62% |
| 5 years ago | $2,371 | +137% |
Return by year (HCA Healthcare)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -16% | $835 (-16%) |
| 2025 | +56% | $1,299 (+30%) |
| 2024 | +11% | $1,440 (+44%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on HCA Healthcare
Loading news…
📋 All analyst calls on HCA
Filtered on — · ✕ show all
▲ Buy · 🎯$460
Price at call : $460.75 — upside -0%
Today : $460.75 — upside -0%
🎯 on HCA : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
RBC Capital ↗
Oct 7, 26
▲ Outperform · 🎯$496
Price at call : $445.01 — upside +11%
Today : $460.75 — upside +8%
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
BMO Capital ↗
Sep 23, 26
▲ Outperform · 🎯$495
Price at call : $436.48 — upside +13%
Today : $460.75 — upside +7%
🎯 on HCA : no call matured yet · 📊 on Health : 60.4% · +8.8% (240 calls)
in progress (365j)
matures : Sep 23, 27
matures : Sep 23, 27
Leerink Partners ↗
Sep 18, 26
▲ Outperform · 🎯$492
Price at call : $425.97 — upside +16%
Today : $460.75 — upside +7%
🎯 on HCA : no call matured yet · 📊 on Health : 53.7% · -6.2% (41 calls)
in progress (365j)
matures : Sep 18, 27
matures : Sep 18, 27
RBC Capital ↗
Sep 8, 26
▲ Outperform · 🎯$435
Price at call : $421.83 — upside +3%
Today : $460.75 — upside -6%
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Sep 8, 27
matures : Sep 8, 27
■ Neutral neutral · not a buy · 🎯$425
Price at call : $429.19 — gap to target -1%
Today : $460.75 — gap to target -8%
🎯 on HCA : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 20, 27
matures : Aug 20, 27
Wells Fargo ↗
Aug 3, 26
■ Equal-Weight neutral · not a buy · 🎯$381
Price at call : $400.73 — gap to target -5%
Today : $460.75 — gap to target -17%
🎯 on HCA : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
Goldman Sachs ↗
Jul 28, 26
▲ Buy · 🎯$485
Price at call : $408.18 — upside +19%
Today : $460.75 — upside +5%
🎯 on HCA : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
See the other 87 calls, newest to oldest
▲ Outperform · 🎯$475
Price at call : $418.19 — upside +14%
Today : $460.75 — upside +3%
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
▲ Buy · 🎯$579
Price at call : $418.19 — upside +38%
Today : $460.75 — upside +26%
🎯 on HCA : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Morgan Stanley ↗
Jul 27, 26
▼ Underweight · 🎯$380
Price at call : $418.19 — upside -9%
Today : $460.75 — upside -18%
🎯 on HCA : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
RBC Capital ↗
Jul 27, 26
▲ Outperform · 🎯$435
Price at call : $418.19 — upside +4%
Today : $460.75 — upside -6%
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Truist Securities ↗
Jul 27, 26
▲ Buy · 🎯$495
Price at call : $418.19 — upside +18%
Today : $460.75 — upside +7%
🎯 on HCA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Oppenheimer ↗
Jul 27, 26
▲ Outperform · 🎯$485
Price at call : $389.62 — upside +24%
Today : $460.75 — upside +5%
🎯 on HCA : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
▲ Overweight · 🎯$435
Price at call : $389.62 — upside +12%
Today : $460.75 — upside -6%
🎯 on HCA : no call matured yet · 📊 on Health : 43.4% · -1.8% (145 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
■ Neutral neutral · not a buy · 🎯$393
Price at call : $389.62 — gap to target +1%
Today : $460.75 — gap to target -15%
🎯 on HCA : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
■ Equal-Weight neutral · not a buy · 🎯$387
Price at call : $389.62 — gap to target -1%
Today : $460.75 — gap to target -16%
🎯 on HCA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
■ Equal-Weight neutral · not a buy · 🎯$402
Price at call : $385.74 — gap to target +4%
Today : $460.75 — gap to target -13%
🎯 on HCA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
RBC Capital ↗
Jul 15, 26
▲ Outperform · 🎯$435
Price at call : $385.74 — upside +13%
Today : $460.75 — upside -6%
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
▲ Overweight · 🎯$475
Price at call : $363.6 — upside +31%
Today : $460.75 — upside +3%
🎯 on HCA : no call matured yet · 📊 on Health : 43.4% · -1.8% (145 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Wells Fargo ↗
Jul 13, 26
■ Equal-Weight neutral · not a buy · 🎯$428
Price at call : $390.74 — gap to target +10%
Today : $460.75 — gap to target -7%
🎯 on HCA : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
■ Equal-Weight neutral · not a buy · 🎯$427
Price at call : $410.61 — gap to target +4%
Today : $460.75 — gap to target -7%
🎯 on HCA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
Cantor Fitzgerald ↗
Jul 7, 26
▲ Overweight · 🎯$525
Price at call : $423.11 — upside +24%
Today : $460.75 — upside +14%
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
▲ Buy · 🎯$431
Price at call : $386.92 — upside +11%
Today : $460.75 — upside -6%
🎯 on HCA : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jun 22, 27
matures : Jun 22, 27
■ Market Perform neutral · not a buy · 🎯$413
Price at call : $372.13 — gap to target +11%
Today : $460.75 — gap to target -10%
🎯 on HCA : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$500
Price at call : $431.92 — upside +16%
Today : $460.75 — upside +9%
🎯 on HCA : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
▲ Overweight · 🎯$496
Price at call : $431.92 — upside +15%
Today : $460.75 — upside +8%
🎯 on HCA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
RBC Capital ↗
Apr 27, 26
▲ Outperform · 🎯$534
Price at call : $431.92 — upside +24%
Today : $460.75 — upside +16%
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
Wells Fargo ↗
Apr 27, 26
■ Equal-Weight neutral · not a buy · 🎯$436
Price at call : $431.92 — gap to target +1%
Today : $460.75 — gap to target -5%
🎯 on HCA : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
Stephens & Co. ↗
Apr 27, 26
▲ Overweight · 🎯$530
Price at call : $431.92 — upside +23%
Today : $460.75 — upside +15%
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
▲ Overweight · 🎯$510
Price at call : $431.92 — upside +18%
Today : $460.75 — upside +11%
🎯 on HCA : no call matured yet · 📊 on Health : 43.4% · -1.8% (145 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
Oppenheimer ↗
Apr 27, 26
▲ Outperform · 🎯$520
Price at call : $445.77 — upside +17%
Today : $460.75 — upside +13%
🎯 on HCA : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
Truist Securities ↗
Apr 27, 26
▲ Buy · 🎯$535
Price at call : $445.77 — upside +20%
Today : $460.75 — upside +16%
🎯 on HCA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
▲ Buy · 🎯$561
Price at call : $537.64 — upside +4%
Today : $460.75 — upside +22%
🎯 on HCA : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Mar 10, 27
matures : Mar 10, 27
▲ Outperform · 🎯$585
Price at call : $525.88 — upside +11%
Today : $460.75 — upside +27%
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Buy · 🎯$635
Price at call : $526.52 — upside +21%
Today : $460.75 — upside +38%
🎯 on HCA : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Feb 23, 27
matures : Feb 23, 27
■ Neutral neutral · not a buy · 🎯$535
Price at call : $535.97 — gap to target -0%
Today : $460.75 — gap to target +16%
🎯 on HCA : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Argus Research ↗
Feb 6, 26
▲ Buy · 🎯$560
Price at call : $497.54 — upside +13%
Today : $460.75 — upside +22%
🎯 on HCA : no call matured yet · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Wells Fargo ↗
Jan 30, 26
■ Equal-Weight neutral · not a buy · 🎯$481
Price at call : $496.85 — gap to target -3%
Today : $460.75 — gap to target +4%
🎯 on HCA : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
▲ Buy · 🎯$590
Price at call : $482.53 — upside +22%
Today : $460.75 — upside +28%
🎯 on HCA : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
RBC Capital ↗
Jan 28, 26
▲ Outperform · 🎯$555
Price at call : $482.53 — upside +15%
Today : $460.75 — upside +20%
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
▲ Buy · 🎯$598
Price at call : $482.53 — upside +24%
Today : $460.75 — upside +30%
🎯 on HCA : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
Cantor Fitzgerald ↗
Jan 28, 26
▲ Overweight · 🎯$588
Price at call : $482.53 — upside +22%
Today : $460.75 — upside +28%
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
▲ Overweight · 🎯$550
Price at call : $482.53 — upside +14%
Today : $460.75 — upside +19%
🎯 on HCA : no call matured yet · 📊 on Health : 43.4% · -1.8% (145 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
Oppenheimer ↗
Jan 28, 26
▲ Outperform · 🎯$540
Price at call : $491.23 — upside +10%
Today : $460.75 — upside +17%
🎯 on HCA : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
Truist Securities ↗
Jan 28, 26
▲ Buy · 🎯$546
Price at call : $491.23 — upside +11%
Today : $460.75 — upside +19%
🎯 on HCA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
Deutsche Bank ↗
Jan 28, 26
▲ Buy · 🎯$558
Price at call : $491.23 — upside +14%
Today : $460.75 — upside +21%
🎯 on HCA : no call matured yet · 📊 on Health : 53.1% · +4.5% (292 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
▲ Overweight · 🎯$551
Price at call : $491.23 — upside +12%
Today : $460.75 — upside +20%
🎯 on HCA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
Wells Fargo ↗
Jan 7, 26
■ Equal-Weight neutral · not a buy · 🎯$452
Price at call : $479.02 — gap to target -6%
Today : $460.75 — gap to target -2%
🎯 on HCA : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
▲ Outperform · 🎯$520
Price at call : $466.56 — upside +11%
Today : $460.75 — upside +13%
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
Cantor Fitzgerald ↗
Oct 7, 25
▲ Overweight · 🎯$444
Price at call : $437.57 — upside +1%
Today : $460.75 — upside -4%
Expected +1% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+0.4%
stock +0% · XLV +17%
matured Oct 7, 26
Cantor Fitzgerald ↗
Aug 26, 25
▲ Overweight · 🎯$444
Price at call : $401.96 — upside +10%
Today : $460.75 — upside -4%
Expected +10% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+6.3%
stock +6% · XLV +27%
matured Aug 26, 26
RBC Capital ↗
Jul 28, 25
▲ Outperform · 🎯$401
Price at call : $344.5 — upside +16%
Today : $460.75 — upside -13%
Expected +16% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+18.5%
stock +18% · XLV +24%
matured Jul 28, 26
RBC Capital ↗
Jun 23, 25
▲ Outperform · 🎯$404
Price at call : $379.02 — upside +7%
Today : $460.75 — upside -12%
Expected +7% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+2.3%
stock +2% · XLV +15%
matured Jun 23, 26
RBC Capital ↗
Apr 28, 25
▲ Outperform · 🎯$376
Price at call : $340.58 — upside +10%
Today : $460.75 — upside -18%
Expected +10% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+27.7%
stock +28% · XLV +3%
matured Apr 28, 26
RBC Capital ↗
Jan 27, 25
▲ Outperform · 🎯$384
Price at call : $328.7 — upside +17%
Today : $460.75 — upside -17%
Expected +17% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+49.5%
stock +49% · XLV +5%
matured Jan 27, 26
Cantor Fitzgerald ↗
Jan 27, 25
▲ Overweight · 🎯$405
Price at call : $332 — upside +22%
Today : $460.75 — upside -12%
Expected +22% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+52.4%
stock +52% · XLV +5%
matured Jan 27, 26
Cantor Fitzgerald ↗
Oct 4, 24
▲ Overweight · 🎯$392
Price at call : $382.53 — upside +2%
Today : $460.75 — upside -15%
Expected +2% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+13.3%
stock +13% · XLV -5%
matured Oct 4, 25
Cantor Fitzgerald ↗
Oct 1, 24
▲ Overweight · 🎯$392
Price at call : $403.85 — upside -3%
Today : $460.75 — upside -15%
Expected -3% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+5.7%
stock +6% · XLV -6%
matured Oct 1, 25
RBC Capital ↗
Aug 23, 24
▲ Outperform · 🎯$405
Price at call : $388.5 — upside +4%
Today : $460.75 — upside -12%
Expected +4% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+3.7%
stock +4% · XLV -12%
matured Aug 23, 25
Cantor Fitzgerald ↗
Aug 20, 24
▲ Overweight · 🎯$392
Price at call : $376.67 — upside +4%
Today : $460.75 — upside -15%
Expected +4% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+7.3%
stock +7% · XLV -11%
matured Aug 20, 25
Cantor Fitzgerald ↗
Aug 19, 24
▲ Overweight · 🎯$392
Price at call : $375.31 — upside +4%
Today : $460.75 — upside -15%
Expected +4% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+9.3%
stock +9% · XLV -11%
matured Aug 19, 25
Cantor Fitzgerald ↗
Jul 25, 24
▲ Overweight · 🎯$392
Price at call : $354.78 — upside +10%
Today : $460.75 — upside -15%
Expected +10% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-4.0%
stock -4% · XLV -10%
matured Jul 25, 25
Cantor Fitzgerald ↗
Jul 24, 24
▲ Overweight · 🎯$335
Price at call : $352.79 — upside -5%
Today : $460.75 — upside -27%
Expected -5% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-5.2%
stock -5% · XLV -8%
matured Jul 24, 25
RBC Capital ↗
Jul 24, 24
▲ Outperform · 🎯$378
Price at call : $352.79 — upside +7%
Today : $460.75 — upside -18%
Expected +7% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
-5.2%
stock -5% · XLV -8%
matured Jul 24, 25
Cantor Fitzgerald ↗
Jul 10, 24
▲ Overweight · 🎯$335
Price at call : $317.51 — upside +6%
Today : $460.75 — upside -27%
Expected +6% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+18.4%
stock +18% · XLV -8%
matured Jul 10, 25
Cantor Fitzgerald ↗
Jul 9, 24
▲ Overweight · 🎯$335
Price at call : $315.35 — upside +6%
Today : $460.75 — upside -27%
Expected +6% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+20.0%
stock +20% · XLV -7%
matured Jul 9, 25
Cantor Fitzgerald ↗
Jul 2, 24
▲ Overweight · 🎯$335
Price at call : $326.55 — upside +3%
Today : $460.75 — upside -27%
Expected +3% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+15.3%
stock +15% · XLV -5%
matured Jul 2, 25
RBC Capital ↗
Apr 29, 24
▲ Outperform · 🎯$329
Price at call : $309.82 — upside +6%
Today : $460.75 — upside -29%
Expected +6% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+11.4%
stock +11% · XLV +0%
matured Apr 29, 25
RBC Capital ↗
Jan 31, 24
▲ Outperform · 🎯$322
Price at call : $314.66 — upside +2%
Today : $460.75 — upside -30%
Expected +2% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+4.9%
stock +5% · XLV +3%
matured Jan 30, 25
Stephens & Co. ↗
Nov 10, 23
▲ Overweight · 🎯$280
Price at call : $229.99 — upside +22%
Today : $460.75 — upside -39%
Expected +22% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+55.6%
stock +56% · XLV +18%
matured Nov 9, 24
▲ Buy · 🎯$275
Price at call : $221.81 — upside +24%
Today : $460.75 — upside -40%
Expected +24% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+63.9%
stock +64% · XLV +19%
matured Oct 24, 24
RBC Capital ↗
Oct 25, 23
▲ Outperform · 🎯$284
Price at call : $221.81 — upside +28%
Today : $460.75 — upside -38%
Expected +28% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+63.9%
stock +64% · XLV +19%
matured Oct 24, 24
Stephens & Co. ↗
Oct 25, 23
▲ Overweight · 🎯$280
Price at call : $221.81 — upside +26%
Today : $460.75 — upside -39%
Expected +26% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+63.9%
stock +64% · XLV +19%
matured Oct 24, 24
RBC Capital ↗
Sep 13, 23
▲ Outperform · 🎯$315
Price at call : $262.49 — upside +20%
Today : $460.75 — upside -32%
Expected +20% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+49.2%
stock +49% · XLV +17%
matured Sep 12, 24
▲ Buy · 🎯$325
Price at call : $294.69 — upside +10%
Today : $460.75 — upside -29%
Expected +10% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+7.0%
stock +7% · XLV +13%
matured Jul 10, 24
▲ Buy · 🎯$305
Price at call : $275.57 — upside +11%
Today : $460.75 — upside -34%
Expected +11% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+18.6%
stock +19% · XLV +12%
matured May 15, 24
RBC Capital ↗
Apr 24, 23
▲ Outperform · 🎯$315
Price at call : $286.25 — upside +10%
Today : $460.75 — upside -32%
Expected +10% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+11.6%
stock +12% · XLV +5%
matured Apr 23, 24
Stephens & Co. ↗
Apr 21, 23
▲ Overweight · 🎯$283
Price at call : $286.25 — upside -1%
Today : $460.75 — upside -39%
Expected -1% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+8.4%
stock +8% · XLV +3%
matured Apr 20, 24
▲ Buy · 🎯$298
Price at call : $272.38 — upside +9%
Today : $460.75 — upside -35%
Expected +9% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+20.1%
stock +20% · XLV +5%
matured Apr 10, 24
RBC Capital ↗
Mar 16, 23
▲ Outperform · 🎯$283
Price at call : $254.38 — upside +11%
Today : $460.75 — upside -39%
Expected +11% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 92% (12 calls matureds) · 📊 on Health : 42.8% · -2.5% (397 calls)
+26.6%
stock +27% · XLV +14%
matured Mar 15, 24
Stephens & Co. ↗
Mar 13, 23
▲ Overweight · 🎯$283
Price at call : $247.07 — upside +15%
Today : $460.75 — upside -39%
Expected +15% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+30.9%
stock +31% · XLV +17%
matured Mar 12, 24
Stephens & Co. ↗
Feb 22, 23
▲ Overweight · 🎯$283
Price at call : $254.1 — upside +11%
Today : $460.75 — upside -39%
Expected +11% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+23.1%
stock +23% · XLV +13%
matured Feb 22, 24
▲ Buy · 🎯$279
Price at call : $253.3 — upside +10%
Today : $460.75 — upside -39%
Expected +10% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+19.1%
stock +19% · XLV +7%
matured Jan 30, 24
▲ Buy · 🎯$265
Price at call : $244.7 — upside +8%
Today : $460.75 — upside -42%
Expected +8% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+12.7%
stock +13% · XLV -3%
matured Dec 14, 23
▲ Buy · 🎯$242
Price at call : $212.75 — upside +14%
Today : $460.75 — upside -47%
Expected +14% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+8.5%
stock +9% · XLV -2%
matured Nov 2, 23
Stephens & Co. ↗
Oct 24, 22
▲ Overweight · 🎯$220
Price at call : $214.4 — upside +3%
Today : $460.75 — upside -52%
Expected +3% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+5.1%
stock +5% · XLV -3%
matured Oct 24, 23
▲ Buy · 🎯$230
Price at call : $211.47 — upside +9%
Today : $460.75 — upside -50%
Expected +9% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+27.4%
stock +27% · XLV +2%
matured Aug 2, 23
▲ Buy · 🎯$210
Price at call : $175.06 — upside +20%
Today : $460.75 — upside -54%
Expected +20% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+70.0%
stock +70% · XLV +2%
matured Jul 1, 23
▲ Buy · 🎯$260
Price at call : $216.3 — upside +20%
Today : $460.75 — upside -44%
Expected +20% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
+28.6%
stock +29% · XLV +3%
matured May 3, 23
▲ Buy · 🎯$290
Price at call : $245.62 — upside +18%
Today : $460.75 — upside -37%
Expected +18% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
-3.0%
stock -3% · XLV -2%
matured Dec 20, 22
Stephens & Co. ↗
Oct 25, 21
▲ Overweight · 🎯$283
Price at call : $241.4 — upside +17%
Today : $460.75 — upside -39%
Expected +17% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-9.9%
stock -10% · XLV -1%
matured Oct 25, 22
▲ Buy · 🎯$275
Price at call : $249.25 — upside +10%
Today : $460.75 — upside -40%
Expected +10% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 83% (12 calls matureds) · 📊 on Health : 51.4% · +3.4% (222 calls)
-27.3%
stock -27% · XLV +1%
matured Jul 21, 22
Stephens & Co. ↗
Jan 29, 20
▲ Overweight · 🎯$180
Price at call : $145.24 — upside +24%
Today : $460.75 — upside -61%
Expected +24% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+12.8%
stock +13% · XLV +14%
matured Jan 28, 21
Stephens & Co. ↗
Jan 14, 19
▲ Overweight · 🎯$143
Price at call : $129.26 — upside +11%
Today : $460.75 — upside -69%
Expected +11% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on HCA : 89% (9 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+14.4%
stock +14% · XLV +19%
matured Jan 14, 20
Frequently asked questions
Should I buy HCA Healthcare stock?
This isn't buy advice. For HCA Healthcare, the analyst consensus is "Buy", with an average price target of $480 (+4% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on HCA Healthcare). We show the numbers — you decide.
Is it too late to buy HCA Healthcare? How high can it go?
The most bullish analyst target on HCA Healthcare is $579 (+26% above today's price); the average is $480. That's the upside they see. Check how reliable those analysts have actually been on HCA Healthcare on our site before trusting it.
Is HCA Healthcare still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 30 analysts have a real record on HCA Healthcare, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in HCA Healthcare? The case for and against
The arguments for and against, one by one, from the numbers: why invest in HCA (and why hesitate).
What has HCA Healthcare's past performance been?
Historical returns and a "how much if I had invested" calculator: HCA performance & returns.
Does HCA Healthcare pay a dividend?
Yield, consistency and growth history of the dividend: HCA's dividend.
What is the best month to buy HCA?
The 12 months ranked by the stock's past returns: best & worst month to buy HCA.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX